Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Public ClinicalTrials.gov record NCT00101608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Intravenous (IV) Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn if vinflunine can shrink or slow the growth of the cancer or increase survival in patients with transitional cell carcinoma of the urothelium. The safety of this treatment will also be studied.
Study identification
- NCT ID
- NCT00101608
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Apr 2007 (Actual)
- Completion
- Apr 2007 (Actual)
- Last update posted
- Mar 2, 2010
2005 – 2007
United States locations
- U.S. sites
- 38
- U.S. states
- 24
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Beverly Hills | California | — | — |
| Local Institution | La Jolla | California | — | — |
| Local Institution | Los Angeles | California | — | — |
| Local Institution | Santa Monica | California | — | — |
| Local Institution | Stanford | California | — | — |
| Local Institution | Vallejo | California | — | — |
| Local Institution | Aurora | Colorado | — | — |
| Local Institution | New Haven | Connecticut | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Miami | Florida | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Honolulu | Hawaii | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Joliet | Illinois | — | — |
| Local Institution | Urbana | Illinois | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | Burlington | Massachusetts | — | — |
| Local Institution | Ann Arbor | Michigan | — | — |
| Local Institution | Detroit | Michigan | — | — |
| Local Institution | Kansas City | Missouri | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | Las Vegas | Nevada | — | — |
| Local Institution | Lebanon | New Hampshire | — | — |
| Local Institution | Buffalo | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | The Bronx | New York | — | — |
| Local Institution | Charlotte | North Carolina | — | — |
| Local Institution | Durham | North Carolina | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Pittsburgh | Pennsylvania | — | — |
| Local Institution | Providence | Rhode Island | — | — |
| Local Institution | Nashville | Tennessee | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Seattle | Washington | — | — |
| Local Institution | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00101608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2010 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00101608 live on ClinicalTrials.gov.